Traded Apr 8 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Mar 23, 2026 · Filed Mar 31, 2026
BioLife Solutions's Chief Quality and Operations sold $49K of BioLife Solutions shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$49,401
Shares × reported transaction price
25 days after results of Feb 26, 2026, 45 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.2% | +3.2% | −1.0% |
| 30 days | +9.9% | +10.0% | 0.0% |
| 90 days | +46.4% | +14.0% | +32.4% |
| 180 days | +103.0% | +16.8% | +86.1% |
Past results only. Not a forecast.
Traded Apr 8 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Apr 8 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Apr 8 · filed 2 days later
Routine share withholding; mechanical by default.